ImmunologybioRxivPreprint
Bhlhe40 Governs T Cell Effector Differentiation with Distinct Requirements in CD4 and CD8 T Cells for Anti-PD-1 and Anti-CTLA-4 Efficacy
Akata Saha, Tomoyuki Minowa, Alexander S. Shavkunov…·Matthew M. Gubin
This study identifies Bhlhe40 as a key regulator of T cell effector differentiation, showing distinct roles in CD4 and CD8 T cells for anti-PD-1 and anti-CTLA-4 therapies.
DOI 10.1101/2025.10.10.681497